ReP USP - Resultado da busca

Artigo de periodico
Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population (2018)
Manriquez, Victor; Aviles, Jorge; Salazar, Luís; Saavedra, Nicolás; Seron, Pamela; Lanas, Fernando; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro
Fonte: Molecular Diagnosis & Therapy. Unidade: FCF
Assuntos: POLIMORFISMO, LEPTINA, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANRIQUEZ, Victor et al. Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population. Molecular Diagnosis & Therapy, v. 22, n. 1, p. 101-113, 2018Tradução . . Disponível em: https://doi.org/10.1007/s40291-017-0306-8. Acesso em: 03 jul. 2024.
APA
Manriquez, V., Aviles, J., Salazar, L., Saavedra, N., Seron, P., Lanas, F., et al. (2018). Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population. Molecular Diagnosis & Therapy, 22( 1), 101-113. doi:10.1007/s40291-017-0306-8
NLM
Manriquez V, Aviles J, Salazar L, Saavedra N, Seron P, Lanas F, Fajardo CM, Hirata MH, Hirata RDC, Cerda A. Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population [Internet]. Molecular Diagnosis & Therapy. 2018 ; 22( 1): 101-113.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s40291-017-0306-8
Vancouver
Manriquez V, Aviles J, Salazar L, Saavedra N, Seron P, Lanas F, Fajardo CM, Hirata MH, Hirata RDC, Cerda A. Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population [Internet]. Molecular Diagnosis & Therapy. 2018 ; 22( 1): 101-113.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s40291-017-0306-8
Artigo de periodico
Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients (2017)
Tamashiro, Erika Yumi; Felipe, Claudia R; Genvigir, Fabiana Dalla Vecchia ; Rodrigues, Alice Cristina ; Campos, Antony B.; Hirata, Rosario Dominguez Crespo ; Silva Junior, Helio Tedesco; Pestana, José O. Medina
Fonte: Drug Metabolism Personalized Theraphy. Unidade: FCF
Assuntos: POLIMORFISMO, TRANSPLANTE DE RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAMASHIRO, Erika Yumi et al. Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients. Drug Metabolism Personalized Theraphy, v. 32, n. 2, p. 89-95, 2017Tradução . . Disponível em: https://doi.org/10.1515/dmpt-2016-0036. Acesso em: 03 jul. 2024.
APA
Tamashiro, E. Y., Felipe, C. R., Genvigir, F. D. V., Rodrigues, A. C., Campos, A. B., Hirata, R. D. C., et al. (2017). Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients. Drug Metabolism Personalized Theraphy, 32( 2), 89-95. doi:10.1515/dmpt-2016-0036
NLM
Tamashiro EY, Felipe CR, Genvigir FDV, Rodrigues AC, Campos AB, Hirata RDC, Silva Junior HT, Pestana JOM. Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients [Internet]. Drug Metabolism Personalized Theraphy. 2017 ; 32( 2): 89-95.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmpt-2016-0036
Vancouver
Tamashiro EY, Felipe CR, Genvigir FDV, Rodrigues AC, Campos AB, Hirata RDC, Silva Junior HT, Pestana JOM. Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients [Internet]. Drug Metabolism Personalized Theraphy. 2017 ; 32( 2): 89-95.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmpt-2016-0036
Artigo de periodico
Pharmacogenetics of drug metabolizing enzymes in Brazilian populations (2014)
Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Interactions. Unidade: FCF
Assuntos: FARMACOGENÉTICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations. Drug Metabolism and Interactions, v. 29, n. 3, p. 153-177, 2014Tradução . . Disponível em: https://doi.org/10.1515/dmdi-2013-0067. Acesso em: 03 jul. 2024.
APA
Cerda, A., Hirata, M. H., & Hirata, R. D. C. (2014). Pharmacogenetics of drug metabolizing enzymes in Brazilian populations. Drug Metabolism and Interactions, 29( 3), 153-177. doi:10.1515/dmdi-2013-0067
NLM
Cerda A, Hirata MH, Hirata RDC. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations [Internet]. Drug Metabolism and Interactions. 2014 ; 29( 3): 153-177.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmdi-2013-0067
Vancouver
Cerda A, Hirata MH, Hirata RDC. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations [Internet]. Drug Metabolism and Interactions. 2014 ; 29( 3): 153-177.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmdi-2013-0067
Trabalho de evento-resumo periodico
Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients (2012)
Luchessi, André Ducati; Germano, J. F; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Silbiger, Vivian Nogueira; Brion, M; Carracedo, A; Tanajura, Luiz Fernando Leite; Lima, P. H. O; Hirata, Thiago Dominguez Crespo; Sousa, A. G
Fonte: Drug Metabolism and Drug Interactions. Nome do evento: Santorine Conference Biologie Prospective. Unidade: FCF
Assuntos: POLIMORFISMO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2012
APA
Luchessi, A. D., Germano, J. F., Hirata, M. H., Hirata, R. D. C., Silbiger, V. N., Brion, M., et al. (2012). Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Luchessi AD, Germano JF, Hirata MH, Hirata RDC, Silbiger VN, Brion M, Carracedo A, Tanajura LFL, Lima PHO, Hirata TDC, Sousa AG. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A28 res. B14.[citado 2024 jul. 03 ]
Vancouver
Luchessi AD, Germano JF, Hirata MH, Hirata RDC, Silbiger VN, Brion M, Carracedo A, Tanajura LFL, Lima PHO, Hirata TDC, Sousa AG. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A28 res. B14.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population (2010)
Oliveira, Raquel; Genvigir, Fabiana Dalla Vecchia; Cerda, Alvaro; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Jorge, M. E. I; Fajardo, Cristina Moreno ; Crema, Daniela; Machado, J. E. A; Martinez, M. B; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidades: HU, FCF
Assuntos: POLIMORFISMO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Raquel et al. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2010
APA
Oliveira, R., Genvigir, F. D. V., Cerda, A., Dórea, E. L., Bernik, M. M. S., Jorge, M. E. I., et al. (2010). Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo.
NLM
Oliveira R, Genvigir FDV, Cerda A, Dórea EL, Bernik MMS, Jorge MEI, Fajardo CM, Crema D, Machado JEA, Martinez MB, Hirata MH, Hirata RDC. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A56-A56 res. A24.[citado 2024 jul. 03 ]
Vancouver
Oliveira R, Genvigir FDV, Cerda A, Dórea EL, Bernik MMS, Jorge MEI, Fajardo CM, Crema D, Machado JEA, Martinez MB, Hirata MH, Hirata RDC. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A56-A56 res. A24.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression (2010)
Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Arazi, Simone Sorkin; Oliveira, Raquel; Dórea, Egidio Lima; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidades: HU, FCF
Assuntos: POLIMORFISMO, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2010
APA
Cerda, A., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R., Dórea, E. L., et al. (2010). Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo.
NLM
Cerda A, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Dórea EL, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A64-A64 res. B4.[citado 2024 jul. 03 ]
Vancouver
Cerda A, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Dórea EL, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A64-A64 res. B4.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals (2008)
Cerda, Alvaro; Arazi, Simone Sorkin; Genvigir, Fabiana Dalla Vecchia; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidades: FCF, HU
Assuntos: POLIMORFISMO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2008
APA
Cerda, A., Arazi, S. S., Genvigir, F. D. V., Hirata, M. H., Dórea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2008). Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cerda A, Arazi SS, Genvigir FDV, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S571 res. W202.[citado 2024 jul. 03 ]
Vancouver
Cerda A, Arazi SS, Genvigir FDV, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S571 res. W202.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Leptin and leptin receptor single nucleotide polymorphisms are associated with obesity and metabolic markers for heart disease in a sample population from Brazil (2008)
Oliveira, Raquel de; Sampaio, Marcelo Ferraz; Armaganijan, Dikran; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Biologie Prospective Santorini Conference. Unidade: FCF
Assuntos: LEPTINA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Raquel de et al. Leptin and leptin receptor single nucleotide polymorphisms are associated with obesity and metabolic markers for heart disease in a sample population from Brazil. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2008
APA
Oliveira, R. de, Sampaio, M. F., Armaganijan, D., Hirata, M. H., & Hirata, R. D. C. (2008). Leptin and leptin receptor single nucleotide polymorphisms are associated with obesity and metabolic markers for heart disease in a sample population from Brazil. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Oliveira R de, Sampaio MF, Armaganijan D, Hirata MH, Hirata RDC. Leptin and leptin receptor single nucleotide polymorphisms are associated with obesity and metabolic markers for heart disease in a sample population from Brazil. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( 8): A135.[citado 2024 jul. 03 ]
Vancouver
Oliveira R de, Sampaio MF, Armaganijan D, Hirata MH, Hirata RDC. Leptin and leptin receptor single nucleotide polymorphisms are associated with obesity and metabolic markers for heart disease in a sample population from Brazil. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( 8): A135.[citado 2024 jul. 03 ]
Artigo de periodico
APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals (2005)
Sorkin, Simone Cohen; Forestiero, Francisco José; Hirata, Mario Hiroyuki ; Guzmán, Elizabeth Cecilia Rodríguez; Cavalli, Selma Andrea; Bertolami, Marcelo Chiara; Salazar, Luís Antônio; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Unidade: FCF
Assuntos: HIPERCOLESTEROLEMIA, GENÉTICA, LIPÍDEOS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SORKIN, Simone Cohen et al. APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals. Clinical Chemistry and Laboratory Medicine, v. 43, n. 12, p. 1339-1345, 2005Tradução . . Disponível em: https://doi.org/10.1515/cclm.2005.229. Acesso em: 03 jul. 2024.
APA
Sorkin, S. C., Forestiero, F. J., Hirata, M. H., Guzmán, E. C. R., Cavalli, S. A., Bertolami, M. C., et al. (2005). APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals. Clinical Chemistry and Laboratory Medicine, 43( 12), 1339-1345. doi:10.1515/cclm.2005.229
NLM
Sorkin SC, Forestiero FJ, Hirata MH, Guzmán ECR, Cavalli SA, Bertolami MC, Salazar LA, Hirata RDC. APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals [Internet]. Clinical Chemistry and Laboratory Medicine. 2005 ; 43( 12): 1339-1345.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/cclm.2005.229
Vancouver
Sorkin SC, Forestiero FJ, Hirata MH, Guzmán ECR, Cavalli SA, Bertolami MC, Salazar LA, Hirata RDC. APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals [Internet]. Clinical Chemistry and Laboratory Medicine. 2005 ; 43( 12): 1339-1345.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/cclm.2005.229

Unidades USP

ReP

Filtros

Autores

Autores USP

Ano de publicação

Assuntos

Indexado em

Afiliação dos autores externos não normalizada